Hematopoietic/Lymphoid Cancer Clinical Trial
Official title:
FEASIBILITY OF IMPLEMENTING PRE-TRANSPLANT EVALUATION BY THE SUPPORTIVE CARE TEAM FOR PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.
PRIMARY OBJECTIVES:
I. Pilot a supportive care intervention that begins prior to transplantation and continues
through the acute peritransplant period.
II. Determine the proportion of patients who enroll and the level of comfort / distress of
hematopoietic cell transplant (HCT) patients who meet with the supportive care team.
III. Pilot data collection mechanisms and cost retrieval in preparation for a randomized
clinical trial.
OUTLINE:
Patients undergo supportive care consultation before transplantation and at least once
monthly while they remain at the transplant center.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02903810 -
Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00710632 -
Screening to Predict Weight Loss in Patients With Cancer
|
N/A | |
| Active, not recruiting |
NCT01056614 -
Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies
|
Phase 2 | |
| Terminated |
NCT00089089 -
Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
|
Phase 1 | |
| Completed |
NCT03654404 -
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
|
N/A | |
| Completed |
NCT01212380 -
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
|
Phase 1 | |
| Completed |
NCT00896792 -
Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers
|
Early Phase 1 | |
| Recruiting |
NCT03110640 -
Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma
|
Phase 1 | |
| Completed |
NCT01982682 -
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
|
Phase 2 | |
| Completed |
NCT00833898 -
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
|
Phase 3 | |
| Active, not recruiting |
NCT05147311 -
Positive Psychology Intervention In HSCT
|
N/A | |
| Completed |
NCT04172818 -
Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families
|
N/A | |
| Completed |
NCT00670917 -
Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
|
N/A | |
| Withdrawn |
NCT00899808 -
Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
|
N/A | |
| Recruiting |
NCT02081937 -
CART-19 Immunotherapy in Mantle Cell Lymphoma
|
Phase 1/Phase 2 | |
| Completed |
NCT02194413 -
Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant
|
N/A | |
| Completed |
NCT01029366 -
CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
|
Phase 1 | |
| Terminated |
NCT03121534 -
Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
|
Phase 2 | |
| Withdrawn |
NCT01620229 -
Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT01866969 -
Quality of Life in Caregivers of Hospitalized Older Patients With Cancer
|
N/A |